Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor
To the Editor: The NCEP guidelines1 focus on lowering LDL-C and also expand the population
to be treated to include individuals at increased risk for coronary heart
disease. This implies that those with clinical evidence of atherosclerosis
elsewhere, multiple risk factors (eg, hypertension, cigarette smoking), and
all patients with diabetes should be taking cholesterol-lowering drugs, primarily
statins, perhaps perpetually.
Rosch PJ. Guidelines for Diagnosis and Treatment of High Cholesterol. JAMA. 2001;286(19):2400-2402. doi:10.1001/jama.286.19.2398